163 related articles for article (PubMed ID: 37190029)
21. Spectroscopic, Viscositic, DNA Binding and Cytotoxic Studies of Newly Synthesized Steroidal Imidazolidines.
Dar AM; Shamsuzzaman ; Khan S
J Fluoresc; 2016 Mar; 26(2):639-49. PubMed ID: 26698876
[TBL] [Abstract][Full Text] [Related]
22. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
Arodola OA; Soliman ME
Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
[TBL] [Abstract][Full Text] [Related]
23. Three Pt-Pt Complexes with Donor-acceptor Feature: Anticancer Activity, DNA Binding Studies and Molecular Docking Simulation.
Ashoo P; Yousefi R; Nabavizadeh SM; Aseman MD; Paziresh S; Ghasemi A; Saboury AA
Anticancer Agents Med Chem; 2019; 19(14):1762-1774. PubMed ID: 31267879
[TBL] [Abstract][Full Text] [Related]
24. Improving of Anticancer Activity and Solubility of Cisplatin by Methylglycine and Methyl Amine Ligands Against Human Breast Adenocarcinoma Cell Line.
Shams Abyaneh FS; Eslami Moghadam M; Divsalar A; Ajloo D; Hosaini Sadr M
Appl Biochem Biotechnol; 2018 Oct; 186(2):271-291. PubMed ID: 29516403
[TBL] [Abstract][Full Text] [Related]
25. Anticancer activity of novel amino acid derivative of palladium complex with phendione ligand against of human colon cancer cell line.
Farhangian H; Eslami Moghadam M; Divsalar A; Rahiminezhad A
J Biol Inorg Chem; 2017 Oct; 22(7):1055-1064. PubMed ID: 28779308
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors.
El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Khalifa MM; Belal A; Rashed M; El-Sharkawy A; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; Eissa IH
Bioorg Chem; 2020 Oct; 103():104233. PubMed ID: 32882440
[TBL] [Abstract][Full Text] [Related]
27. Mono- and bis-pyrazolophthalazines: Design, synthesis, cytotoxic activity, DNA/HSA binding and molecular docking studies.
Hamidinasab M; Ameri A; Hekmat A; Forootanfar H; Mortezazadeh T; Bodaghifard MA; Peytam F; Esmaeili R; Foroumadi A; Sharifzadeh M; Mobinikhaledi A; Khoobi M
Bioorg Med Chem; 2021 Jan; 30():115944. PubMed ID: 33352388
[TBL] [Abstract][Full Text] [Related]
28. Property evaluation of two anticancer candidate platinum complexes with N-isobutyl glycine ligand against human colon cancer.
Hosseini Hashemi Z; Mirzaei M; Eslami Moghadam M
Biometals; 2022 Oct; 35(5):987-1009. PubMed ID: 35829930
[TBL] [Abstract][Full Text] [Related]
29. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers.
Abbass EM; Khalil AK; Mohamed MM; Eissa IH; El-Naggar AM
Bioorg Chem; 2020 Nov; 104():104255. PubMed ID: 32927130
[TBL] [Abstract][Full Text] [Related]
30. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
[TBL] [Abstract][Full Text] [Related]
31. Rational design and interaction studies of combilexins towards duplex DNA.
Dileep KV; Vijeesh V; Remya C
Mol Biosyst; 2016 Mar; 12(3):860-7. PubMed ID: 26757743
[TBL] [Abstract][Full Text] [Related]
32. Troxerutin, a natural flavonoid binds to DNA minor groove and enhances cancer cell killing in response to radiation.
Panat NA; Singh BG; Maurya DK; Sandur SK; Ghaskadbi SS
Chem Biol Interact; 2016 May; 251():34-44. PubMed ID: 27016192
[TBL] [Abstract][Full Text] [Related]
33. DNA as a Target for Anticancer Phen-Imidazole Pd(II) Complexes.
Heydari M; Moghadam ME; Tarlani A; Farhangian H
Appl Biochem Biotechnol; 2017 May; 182(1):110-127. PubMed ID: 27933484
[TBL] [Abstract][Full Text] [Related]
34. A DNA intercalation methodology for an efficient prediction of ligand binding pose and energetics.
Soni A; Khurana P; Singh T; Jayaram B
Bioinformatics; 2017 May; 33(10):1488-1496. PubMed ID: 28073762
[TBL] [Abstract][Full Text] [Related]
35. A thermodynamic signature for drug-DNA binding mode.
Chaires JB
Arch Biochem Biophys; 2006 Sep; 453(1):26-31. PubMed ID: 16730635
[TBL] [Abstract][Full Text] [Related]
36. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
Kale MA; Sonwane GM
Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
[TBL] [Abstract][Full Text] [Related]
37. Bioactive platinum complex of ligand bearing pyrimidine skeleton: DNA/BSA binding, molecular docking, anticancer, antioxidant and antimicrobial activities.
Sankarganesh M; Adwin Jose PR; Dhaveethu Raja J; Vijay Solomon R; Dorothy Sheela C; Gurusamy S
J Biomol Struct Dyn; 2022 Sep; 40(15):6683-6696. PubMed ID: 33634734
[TBL] [Abstract][Full Text] [Related]
38. Xanthone Conjugated Amino Acids as Potential Anticancer and DNA Binding Agents: Molecular Docking, Cytotoxicity and SAR Studies.
Rakesh KP; Darshini N; Manukumar HM; Vivek HK; Eissa MYH; Prasanna DS; Mallesha N
Anticancer Agents Med Chem; 2018; 18(15):2169-2177. PubMed ID: 30179146
[TBL] [Abstract][Full Text] [Related]
39. Studies of DNA-binding properties of lafutidine as adjuvant anticancer agent to calf thymus DNA using multi-spectroscopic approaches, NMR relaxation data, molecular docking and dynamical simulation.
Yang H; Tang P; Tang B; Huang Y; He J; Li S; Li H
Int J Biol Macromol; 2017 Jun; 99():79-87. PubMed ID: 28235605
[TBL] [Abstract][Full Text] [Related]
40. Comparative studies on DNA-binding and in vitro antitumor activity of enantiomeric ruthenium(II) complexes.
Hong WX; Huang F; Huan T; Xu X; Han Q; Wang G; Xu H; Duan S; Duan Y; Long X; Liu Y; Hu Z
J Inorg Biochem; 2018 Mar; 180():54-60. PubMed ID: 29245062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
